Pharmacological ZO-1 agonist treatment attenuates ammonia nitrogen stress-induced mucosal inflammation and intestinal barrier failure in Leiocassis longirostris - Takeaways - MDSpire

Pharmacological ZO-1 agonist treatment attenuates ammonia nitrogen stress-induced mucosal inflammation and intestinal barrier failure in Leiocassis longirostris

  • By

  • Senyue Liu

  • Yang Feng

  • Chengyan Mou

  • Lu Zhang

  • Yuanliang Duan

  • Zhipeng Huang

  • Han Zhao

  • Jian Zhou

  • Jun Du

  • Qiang Li

  • Yongqiang Deng

  • June 8, 2026

  • 0 min

Share

  • 1

    Ammonia nitrogen exposure induces inflammatory cell infiltration and disrupts the intestinal epithelial barrier in Leiocassis longirostris.

  • 2

    Despite upregulated transcripts of tight junction components, protein assembly at the apical membrane is severely disrupted under ammonia stress.

  • 3

    Pharmacological stabilization of ZO-1 reduces mucosal inflammatory damage and restores tight junction protein localization and barrier function.

  • 4

    The study identifies a pattern of ineffective transcriptional compensation in response to ammonia-induced mucosal dysregulation.

  • 5

    Stabilizing ZO-1 may strengthen intestinal mucosal resilience, providing insights for sustainable aquaculture practices.

Original Source(s)

Related Content